MR编号 | SE/H/1720/001 |
---|
药品名称 | Finomel Perifer |
---|
活性成分 | - alanine 20.7 g/l
- arginine 11.5 g/l
- CALCIUMCHLORID dihydrate 0.74 g/l
- fish oil, rich in omega 3-acids 40.0 g/l
- glucose 130.0 g/l
- glycine 10.3 g/l
- histidine 4.8 g/l
- isoleucine 6.0 g/l
- leucine 7.3 g/l
- lysine 5.8 g/l
- MAGNESIUMSULFAT 2.47 g/l
- medium-chain triglycerides 50.0 g/l
- methionine 4.0 g/l
- olive oil 50.0 g/l
- phenylalanine 5.6 g/l
- potassium chloride acetate 4.48 g/l
- proline 6.8 g/l
- serine 5.0 g/l
- sodium acetate 5.62 g/l
- sodium glycerophosphate hydrate 5.92 g/l
- soybean oil 60.0 g/l
- threonine 4.2 g/l
- tryptophan 1.8 g/l
- tyrosine 0.4 g/l
- valine 5.8 g/l
- zinc sulfate 0.02 g/l
|
---|
剂型 | Emulsion for infusion |
---|
上市许可持有人 | Baxter Medical AB
Sweden |
---|
参考成员国 - 产品名称 | Sweden (SE) |
---|
互认成员国 - 产品名称 | - Greece (GR)
- Norway (NO)
Finomel Perifer - Finland (FI)
- Poland (PL)
Finomel Peri - Czechia (CZ)
FINOMEL, infuzní emulze - Germany (DE)
Finomel - Netherlands (NL)
Finomel Peri, Finomel - Luxembourg (LU)
Periomegomel, Emulsion pour perfusion - Iceland (IS)
Finomel Perifer innrennslislyf, fleyti - United Kingdom (Northern Ireland) (XI)
- Belgium (BE)
Periomegomel émulsion pour perfusion - Denmark (DK)
- Italy (IT)
- Spain (ES)
- France (FR)
- Austria (AT)
Finomel Peri Emulsion zur Infusion - Ireland (IE)
|
---|
许可日期 | 2018/11/28 |
---|
最近更新日期 | 2024/08/28 |
---|
药物ATC编码 | 申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Bibliographic Art 10 a Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|
|
---|